• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Tetrahydroisoquinolines Tetrahydroisoquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Tetrahydroisoquinolines

Comprehensive Overview of 6-Nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride (CAS No. 174648-98-7)

6-Nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride (CAS No. 174648-98-7) is a chemically significant compound widely studied in pharmaceutical and organic chemistry research. This derivative of tetrahydroisoquinoline features a nitro group at the 6-position, which enhances its reactivity and potential applications in drug discovery. Researchers often explore its role as a building block for synthesizing more complex molecules, particularly in the development of central nervous system (CNS) targeting agents.

The compound's hydrochloride salt form improves solubility, making it suitable for various experimental protocols. Recent trends in AI-driven drug discovery and high-throughput screening have renewed interest in nitrogen-containing heterocycles like this compound. Its structural features align with the search for novel bioactive scaffolds, a hot topic in medicinal chemistry forums and research publications.

Analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry are commonly employed to characterize 6-Nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride. The compound's stability under different pH conditions and thermal properties are frequently discussed in chemical databases and patent literature. These studies are crucial for optimizing its use in multi-step synthetic routes.

In the context of green chemistry, researchers are investigating eco-friendly methods to synthesize this compound. Questions about its catalytic reduction pathways and solvent-free reactions appear frequently in academic search queries. Such approaches address the growing demand for sustainable chemical processes while maintaining high yields.

The pharmacological potential of 6-Nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride derivatives continues to attract attention. Computational studies using molecular docking and QSAR modeling explore its interactions with biological targets. These methods help predict its ADMET properties (absorption, distribution, metabolism, excretion, and toxicity), a key focus area in preclinical research.

From a commercial perspective, suppliers often list this compound under categories like research chemicals and fine chemicals. Its pricing and availability fluctuate based on custom synthesis demand and bulk order volumes. Laboratories frequently inquire about analytical certificates and storage recommendations, reflecting practical concerns in handling this material.

Emerging applications in material science have expanded the relevance of 6-Nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride beyond pharmaceuticals. Its potential use in organic electronics and photoactive materials is being explored, particularly in academic institutions with nanotechnology research programs.

Safety data sheets emphasize standard laboratory precautions when working with this compound. While not classified as hazardous under normal conditions, proper personal protective equipment (PPE) and ventilation systems are recommended during handling, consistent with general chemical safety protocols.

The compound's patent landscape reveals numerous applications in intellectual property filings, particularly for neurological disorder treatments. This aligns with increasing public interest in neuroprotective agents and cognitive enhancers, as reflected in health-related search trends.

Future research directions may explore the structure-activity relationships of modified versions of this scaffold. The scientific community shows growing curiosity about its isosteric replacements and bioisosteric analogs, topics that frequently appear in chemistry conference proceedings and grant proposals.

• 208589-95-1(2-Benzyl-6-nitro-1,2,3,4-tetrahydroisoquinoline)
• 186390-77-2(6-Nitro-1,2,3,4-tetrahydroisoquinoline)
• 99365-69-2(7-Nitro-1,2,3,4-tetrahydroisoquinoline Hydrochloride)
• 168897-26-5(Isoquinoline, 1,2,3,4-tetrahydro-2-[2-(4-nitrophenyl)ethyl]-)
• 223915-75-1(8-Nitro-2,3,4,5-tetrahydro-1H-benzo[c]azepine)
• 42923-79-5(7-Nitro-1,2,3,4-tetrahydroisoquinoline)
• 711601-13-7(2-Ethyl-7-nitro-1,2,3,4-tetrahydroisoquinoline)
• 14097-35-9(2-methyl-7-nitro-1,2,3,4-tetrahydroisoquinoline)
• 168897-56-1(Isoquinoline, 1,2,3,4-tetrahydro-2-[(3-nitrophenyl)methyl]-)
• 1187932-26-8(6-Nitro-1,2,3,4-tetrahydro-isoquinoline Hydrobromide)